In EGFR-mutant GBM, which do not usually possess the mutations in IDH or H3 histone family 3A (H3F3A) to potentially change the epigenetics, constitutive PI3K activation could engage the epigenetic machinery through several complementary routes. The gene discussed is EGFR; the disease is glioblastoma.